Global Treprostinil Market Growth 2019-2024

Published On: Jan 2019

Format: PDF

Publisher: LP Infomation

Pages: 135

Report ID: 224453

Treprostinil is a vasodilator that is used for the treatment of pulmonary arterial hypertension.

According to this study, over the next five years the Treprostinil market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Treprostinil business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Treprostinil market by product type, application, key manufacturers and key regions and countries.

This study considers the Treprostinil value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.
Inhalation form
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.
Drug store

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
United States
Southeast Asia
Middle East & Africa
South Africa
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
United Therapeutics Corporation

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Treprostinil consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
To understand the structure of Treprostinil market by identifying its various subsegments.
Focuses on the key global Treprostinil manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Treprostinil with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Treprostinil submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2018-2023 Global Treprostinil Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Treprostinil Consumption 2013-2023
2.1.2 Treprostinil Consumption CAGR by Region
2.2 Treprostinil Segment by Type
2.2.1 Injection
2.2.2 Inhalation form
2.3 Treprostinil Consumption by Type
2.3.1 Global Treprostinil Consumption Market Share by Type (2013-2018)
2.3.2 Global Treprostinil Revenue and Market Share by Type (2013-2018)
2.3.3 Global Treprostinil Sale Price by Type (2013-2018)
2.4 Treprostinil Segment by Application
2.4.1 Hospital
2.4.2 Drug store
2.5 Treprostinil Consumption by Application
2.5.1 Global Treprostinil Consumption Market Share by Application (2013-2018)
2.5.2 Global Treprostinil Value and Market Share by Application (2013-2018)
2.5.3 Global Treprostinil Sale Price by Application (2013-2018)

3 Global Treprostinil by Players
3.1 Global Treprostinil Sales Market Share by Players
3.1.1 Global Treprostinil Sales by Players (2016-2018)
3.1.2 Global Treprostinil Sales Market Share by Players (2016-2018)
3.2 Global Treprostinil Revenue Market Share by Players
3.2.1 Global Treprostinil Revenue by Players (2016-2018)
3.2.2 Global Treprostinil Revenue Market Share by Players (2016-2018)
3.3 Global Treprostinil Sale Price by Players
3.4 Global Treprostinil Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Treprostinil Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Treprostinil Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Treprostinil by Regions
4.1 Treprostinil by Regions
4.1.1 Global Treprostinil Consumption by Regions
4.1.2 Global Treprostinil Value by Regions
4.2 Americas Treprostinil Consumption Growth
4.3 APAC Treprostinil Consumption Growth
4.4 Europe Treprostinil Consumption Growth
4.5 Middle East & Africa Treprostinil Consumption Growth

5 Americas
5.1 Americas Treprostinil Consumption by Countries
5.1.1 Americas Treprostinil Consumption by Countries (2013-2018)
5.1.2 Americas Treprostinil Value by Countries (2013-2018)
5.2 Americas Treprostinil Consumption by Type
5.3 Americas Treprostinil Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6.1 APAC Treprostinil Consumption by Countries
6.1.1 APAC Treprostinil Consumption by Countries (2013-2018)
6.1.2 APAC Treprostinil Value by Countries (2013-2018)
6.2 APAC Treprostinil Consumption by Type
6.3 APAC Treprostinil Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Treprostinil by Countries
7.1.1 Europe Treprostinil Consumption by Countries (2013-2018)
7.1.2 Europe Treprostinil Value by Countries (2013-2018)
7.2 Europe Treprostinil Consumption by Type
7.3 Europe Treprostinil Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Treprostinil by Countries
8.1.1 Middle East & Africa Treprostinil Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Treprostinil Value by Countries (2013-2018)
8.2 Middle East & Africa Treprostinil Consumption by Type
8.3 Middle East & Africa Treprostinil Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Treprostinil Distributors
10.3 Treprostinil Customer

11 Global Treprostinil Market Forecast
11.1 Global Treprostinil Consumption Forecast (2018-2023)
11.2 Global Treprostinil Forecast by Regions
11.2.1 Global Treprostinil Forecast by Regions (2018-2023)
11.2.2 Global Treprostinil Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Treprostinil Forecast by Type
11.8 Global Treprostinil Forecast by Application

12 Key Players Analysis
12.1 United Therapeutics Corporation
12.1.1 Company Details
12.1.2 Treprostinil Product Offered
12.1.3 United Therapeutics Corporation Treprostinil Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 United Therapeutics Corporation News
12.2 Sandoz
12.2.1 Company Details
12.2.2 Treprostinil Product Offered
12.2.3 Sandoz Treprostinil Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Sandoz News

13 Research Findings and Conclusion